NSC57969

Stock Code: 3575473
Manufacturer Part No: SML1863-5MG
Order Now for 7 day delivery
£150.43 (exc VAT) per 5MG
Quantity: - +

Biochem/physiol Actions


NSC57969 is a MDR-selective compound that exhibits a robust Pgp-dependent toxic activity across diverse cancer cell lines. NSC57969 shows profound toxicity against doxorubicin resistant Brca1-/-;p53-/- spontaneous mouse mammary carcinoma cells. NSC57969 eradicates P-glycoprotein expression in doxorubicin resistant brca1-/-;p53-/- spontaneous mouse mammary carcinoma, and MES-SA/Dx5 cells. However treatment of normal cells (hCMEC/D3 cells) with NSC57969 does not induce loss of Pgp.


Packaging


5, 25 mg in glass bottle

Colourwhite to beige
Quality Level100
InChI keyWXMFPLZGDXLEMN-UHFFFAOYSA-N
InChI1S/C15H18N2O/c18-15-13(11-17-9-2-1-3-10-17)7-6-12-5-4-8-16-14(12)15/h4-8,18H,1-3,9-11H2
ManufacturerSIGMA-ALDRICH
SolubilityDMSO: 5 mg/mL, clear (warmed)
Formpowder
Assay≥98% (HPLC)

There are no downloads for this product.